Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
Journal
Allergy: European Journal of Allergy and Clinical Immunology
Year
2025
Conclusion
ARIA-EAACI 2024–2025 will provide major advances for the management of patients with AR. Building on several different sources of evidence, ARIA-EAACI 2024–2025 will adopt a patient-centred perspective and promote shared decision-making. The formulation of recommendations will be fully based on the GRADE working group methodology. Nevertheless, the development of ARIA-EAACI 2024–2025 will contribute per se to methodological innovations for the guideline development process in aspects such as the use of AI to support the development of questions, or the incorporation of evidence from multiple complementary sources (Table 1). As its end product, ARIA-EAACI 2024–2025 aims not only at producing a set of recommendations but also at developing a set of digitalised management algorithms, which will be essential in promoting a continuative and long-standing integration of these guidelines into daily care.
Resources and Links
Phone Number: +603 2781 4519 / +603 2781 4520
https://onlinelibrary.wiley.com/doi/10.1111/all.70100
Share the Page
|
|
Information
Consultant Name
Dr Amir Hamzah Abdul Latiff
For general questions about clinical trials
Phone Number: +603 2781 4519 / +603 2781 4520
Clinical trials are part of research studies involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions. They are critical to the advancement of medicine and improving patient health. Participating in clinical trials offers patients the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.
In Pantai Hospital Kuala Lumpur, clinical trials are carried out under our Clinical Research team.
If you would like to participate in any of our clinical trials or would like to know, please provide your information below and we will be in touch with you:


